Therapeutic potential of salidroside in type I diabetic erectile dysfunction: Attenuation of oxidative stress and apoptosis via the Nrf2/HO-1 pathway
PLOS ONE · 11.07.2024 · 19 (7) · e0306926
DOI: 10.1371/journal.pone.0306926 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 11.07.2024. Verfasst von Zhenghao Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Oxidative Stress, Erectile Dysfunction, Apoptosis, NF-E2-Related Factor 2. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The primary objective of this work was to delve into the potential therapeutic advantages and dissect the molecular mechanisms of salidroside in enhancing erectile function in rats afflicted with diabetic microvascular erectile dysfunction (DMED), addressing both the whole-animal and cellular dimensions.We established a DMED model in Sprague‒Dawley (SD) rats and conducted in vivo experiments. The DMED rats were administered varying doses of salidroside, the effects of which on DMED were compared. Erectile function was evaluated by applying electrical stimulation to the cavernous nerves and measuring intracavernous pressure in real time. The penile tissue underwent histological examination and Western blotting. Hydrogen peroxide (H2O2) was employed in the in vitro trial to induce an oxidative stress for the purpose of identifying alterations in cell viability. The CCK-8 assay was used to measure the viability of corpus cavernous smooth muscle cells (CCSMCs) treated with vs. without salidroside. Flow cytometry was utilized to detect alterations in intracellular reactive oxygen species (ROS). Apoptosis was assessed through Western blotting and TdT-mediated dUTP nick-end labelling (TUNEL). Animal and cellular experiments indicate that the Nrf2/HO-1 signalling pathway may be upregulated by salidroside, leading to the improvement of erectile function in diabetic male rats by alleviating oxidative stress and reducing apoptosis in corpus cavernosum tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
- Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Second Department of Surgery, Shandong Rongjun General Hospital, Jinan, Shandong, China.
- Key Laboratory of Urinary Diseases in Universities of Shandong (Shandong First Medical University), Jinan, Shandong, China.
- Engineering Laboratory of Urinary Organ and Functional Reconstruction of Shandong Province, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
ORCID-Profile: Qiang Fu
Zitieren
APA
Li, Z., Jia, B., Guo, Z., Zhang, K., Zhao, D., Li, Z., & Fu, Q. (2024). Therapeutic potential of salidroside in type I diabetic erectile dysfunction: Attenuation of oxidative stress and apoptosis via the Nrf2/HO-1 pathway. PLOS ONE, 19(7), e0306926. https://doi.org/10.1371/journal.pone.0306926
Vancouver
Li Z, Jia B, Guo Z, Zhang K, Zhao D, Li Z, et al. Therapeutic potential of salidroside in type I diabetic erectile dysfunction: Attenuation of oxidative stress and apoptosis via the Nrf2/HO-1 pathway. PLOS ONE. 2024;19(7):e0306926. doi:10.1371/journal.pone.0306926
BibTeX
@article{Li2024,
author = {Li, Zhenghao and Jia, Bin and Guo, Zhongkai and Zhang, Keqin and Zhao, Danfeng and Li, Ziheng and Fu, Qiang},
title = {Therapeutic potential of salidroside in type I diabetic erectile dysfunction: Attenuation of oxidative stress and apoptosis via the Nrf2/HO-1 pathway},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {7},
pages = {e0306926},
doi = {10.1371/journal.pone.0306926}
}
EUVIMED